Relative risks of reported serious injury and death associated with hemostasis devices by gender

Pharmacoepidemiology and Drug Safety

Volumn 12, Issue 3, 2003, Pages 237-241

  Tavris, Dale R ^a   Gallauresi, Beverly ^b   Rich, Suzanne ^b   Bell, Carlos ^b  

^a Epidemiology Branch   (United States)

^b Ctr Devices and Radiological Hlth   (United States)

Author keywords

Cardiac catheterization; Hemostasis device; Medical device reporting

Indexed keywords

ARTICLE; BLEEDING; BLOOD VESSEL INJURY; CAUSE OF DEATH; CONTROLLED STUDY; DEVICE; DEVICE INFECTION; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH STATISTICS; HEART CATHETERIZATION; HEMATOMA; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DATABASES, FACTUAL; EQUIPMENT AND SUPPLIES; EQUIPMENT SAFETY; FEMALE; FEMORAL ARTERY; HEMATOMA; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; INFECTION; MALE; NATIONAL CENTER FOR HEALTH STATISTICS (U.S.); RISK ASSESSMENT; SEX FACTORS; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WOUNDS AND INJURIES;

EID: 0037390883     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.802     Document Type: Article

References (16)

1. United States Food and Drug Administration (U.S. FDA). Mandatory and User Facility Device Experience [MAUDE Database, 2001]. Available World Wide Web: http://www.accessdata. fda.gov/scripts/cdrh/cfdocs/cfMAUDE.
2. United States Centers for Disease Control and Prevention (U.S. CDC)/National Center for Health Statistics (NCHS). National Hospital Discharge Survey, 1996. Series 13, No. 139-140.
3. Kussmaul WG, III, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. Am J Cardiol 1995; 25(7): 1685-1692.
4. Shrake KL. Comparison of major complication rates associated with four methods of arterial closure. Am J Cardiol 2000; 85: 1024-1025.
5. Silba S. Review: rapid hemostasis of arterial puncture sites with collagen in patients undergoing diagnostic and interventional cardiac catheterization. Clin Cardiol 1997; 20: 981-992.
6. Gerckens U, Cattelaens N, Lampe E, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol 1999; 83: 1658-1663.
7. Sanborn TA, Gibbs HH, Brinker JA, et al. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993; 22: 1273-1279.
8. Carere RG, Webb JG, Miyagishima R, et al. Groin complications associated with collagen plug closure of femoral arterial puncture sites in anticoagulated patients. Cathet Cardiovasc Diagn 1998; 43: 124-129.
9. Von Hoch F, Neumann FJ, Theiss W, Kastrati A, Schomig A. Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation: a randomized study. Eur Heart J 1994; 16: 640-646.
10. Sesana M, Vaghetti M, Albiero R, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invas Cardiol 2000; 12: 395-399.
11. United States Food and Drug Administration (U.S. FDA). Complications related to the use of vascular hemostasis devices [October 8, 1999]. Available World Wide Web: http://www.accessdata.fda.gov/cdrh/safety.html.
12. United States General Accounting Office (U.S. GAO). Medical devices: early warning of problems is hampered by severe underreporting (GAO/PEMD-87-1, December 19, 1986).
13. Juergens CP, Semsarian C, Keech AC, Beller EM, Harris PJ. Hemorrhagic complications of intravenous heparin use. Am J Cardiol 1997; 80: 150-154.
14. Motwant JG, Topol EJ. Aortocornary saphenous vein graft disease: pathogenesis, predisposition and prevention. Circulation 1998; 97(9): 916-931.
15. Johnson LW, Esente P, Giambartolomel A, et al. Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet Cardiovasc Diagn 1994; 31: 165-172.
16. Dauerman HL, Andreou C, Perras MA, et al. Predictors of bleeding complications after rescue coronary interventions. J Thromb Thrombolysis 2000; 10: 83-88.